Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 3236 (etonogestrel) in men with LUTS suggestive of BPH
2007-005793-31Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Org 3236 (etonogestrel) with Placebo (2 arms). Primary endpoint: Prostate volume. Started Jan 2008; status: completed.
02
Drugs
etonogestrel
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2007-005793-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005793-31.